Page last updated: 2024-10-30

2-mercaptoethylguanidine and Cardiomyopathies

2-mercaptoethylguanidine has been researched along with Cardiomyopathies in 1 studies

2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soejima, K1
Schmalstieg, FC1
Traber, LD1
Szabo, C1
Salzman, A1
Traber, DL1

Other Studies

1 other study available for 2-mercaptoethylguanidine and Cardiomyopathies

ArticleYear
Role of nitric oxide in myocardial dysfunction after combined burn and smoke inhalation injury.
    Burns : journal of the International Society for Burn Injuries, 2001, Volume: 27, Issue:8

    Topics: Analysis of Variance; Animals; Burns; Cardiomyopathies; Disease Models, Animal; Female; Guanidines;

2001